ReviewBiomedicines2026

Potential Role of the Triple Receptor Agonist Retatrutide in Antipsychotic-Associated Metabolic Dysfunction Among Clozapine- and Olanzapine-Treated Schizophrenia Spectrum Disorders: A Narrative Review and Theoretical Framework.

Michael Mieczyslaw Kaczynski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.